Please use this identifier to cite or link to this item: http://hdl.handle.net/11189/4729
DC FieldValueLanguage
dc.contributor.authorSzucs, Gergo-
dc.contributor.authorBester, Dirk J-
dc.contributor.authorKupai, Krisztina-
dc.contributor.authorCsont, Tamás-
dc.contributor.authorCsonka, Csaba-
dc.contributor.authorEsterhuyse, Adriaan J-
dc.contributor.authorFerdinandy, Peter-
dc.contributor.authorVan Rooyen, Jacques-
dc.date.accessioned2016-07-26T07:34:12Z-
dc.date.available2016-07-26T07:34:12Z-
dc.date.issued2011-
dc.identifier.urihttp://dx.doi.org/10.1186/1476-511X-10-103-
dc.identifier.urihttp://hdl.handle.net/11189/4729-
dc.description.abstractBACKGROUND AND AIMS: The effect of red palm oil (RPO) supplementation on infarct size after ischaemia/reperfusion in a cholesterol enriched diet-induced hyperlipidemic animal model has not been reported. Previous studies reported results on the effect of RPO in a normal diet, whilst evidence of protection has been linked to improved functional recovery, prosurvival kinase, anti-apoptosis and NO-cGMP. Therefore, we aimed to investigate the effects of dietary RPO supplementation in a cholesterol-enriched diet-induced hyperlipidemic rat model and to investigate the involvement of matrix metalloproteinase 2 (MMP2) inhibition as a possible mechanism of protection. MATERIALS AND METHODS: Male Wistar rats were fed either a standard rat chow diet (Norm) or a 2% cholesterol-enriched diet (Chol) for nine weeks. Additionally, two more groups received the same treatment, however, at the week 4, diet was supplemented with RPO for the last five weeks (Norm+RPO and Chol+RPO), respectively. After the feeding period hearts were isolated, perfused according to Langendorff and subjected to 30 minutes of normothermic global ischaemia followed by two hours of reperfusion. Infarct size was measured by 2,3,5-triphenyltetrazolium chloride staining at the end of reperfusion. RESULTS: Cholesterol-enriched diet increased myocardial infarct size from 23.5±3.0% to 37.2±3.6% (p<0.05) when compared to normal diet. RPO supplementation significantly reduced infarct size either in Norm+RPO or in Chol+RPO (to 9.2±1.0% and 26.9±3.0%), respectively. Infarct size in Chol+RPO was comparable to the Norm group. MMP2 activity before ischaemia was significantly reduced in the Chol+RPO group when compared to the Chol group. However, the MMP2 activity of the hearts of the RPO fed rats was significantly increased when compared to the normal diet group after ischaemia. CONCLUSIONS: For the first time it was shown that dietary RPO supplementation attenuated the increased susceptibility of the hearts in cholesterol fed rats to ischaemia/reperfusion injury. This was shown by reduced infarct size. For the first time we also show that red palm oil supplementation altered pre-ischaemic levels of MMP-2, which may indicate that myocardial MMP2 may be implicated as a possible role player in RPO mediated protection against ischaemia/reperfusion injury in hearts of cholesterol supplemented rats.en_US
dc.description.sponsorshipThis work was supported by a Collaborative Research Grant between Hungary (ZA-35/2006) and South Africa (NRF: 62212) and by grants from the National Office for Research and Technology (Jedlik-NKFP-A1-2006-029, Med-Food, Baross DA-TECH-07-2008-0041, TAMOP-4.2.2-08/1/2008-0013, TAMOP-4.2.1/B-09/1/KONV-2010-0005). T. Csont holds a "János Bolyai Felowship" from the Hungarian Academy of Sciences.en_US
dc.language.isoenen_US
dc.publisherBioMed Centralen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/za/en
dc.subjectRed palm oil (RPO)en_US
dc.subjectCholesterol fed ratsen_US
dc.subjectDieten_US
dc.subjectProsurvival kinaseen_US
dc.titleDietary red palm oil supplementation decreases infarct size in cholesterol-fed ratsen_US
dc.type.patentArticleen_US
Appears in Collections:HWSci - Journal Articles (DHET subsidised)
Show simple item record

Page view(s)

74
Last Week
0
Last month
0
checked on Sep 2, 2026

Download(s)

30
checked on Sep 2, 2026

Google ScholarTM

Check


This item is licensed under a Creative Commons License Creative Commons